Bioneutra Global Stock Buy Hold or Sell Recommendation
| BGACF Stock | USD 0.07 0.00 0.00% |
Assuming the 90 days horizon and your bold attitude towards risk, our recommendation regarding BioNeutra Global is 'Strong Sell'. Macroaxis provides BioNeutra Global buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BGACF positions.
Check out BioNeutra Global Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as BioNeutra and provide practical buy, sell, or hold advice based on investors' constraints. BioNeutra Global. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
BioNeutra |
Execute BioNeutra Global Buy or Sell Advice
The BioNeutra recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioNeutra Global. Macroaxis does not own or have any residual interests in BioNeutra Global or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioNeutra Global's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
BioNeutra Global Trading Alerts and Improvement Suggestions
| BioNeutra Global generated a negative expected return over the last 90 days | |
| BioNeutra Global has some characteristics of a very speculative penny stock | |
| BioNeutra Global has high likelihood to experience some financial distress in the next 2 years | |
| BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| About 37.0% of the company shares are held by company insiders |
BioNeutra Global Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioNeutra Global or Consumer Defensive sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioNeutra Global's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioNeutra pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
BioNeutra Global Volatility Alert
At this time BioNeutra Global exhibits very low volatility. BioNeutra Global is a penny stock. Although BioNeutra Global may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in BioNeutra Global. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on BioNeutra instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.BioNeutra Global Fundamentals Vs Peers
Comparing BioNeutra Global's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioNeutra Global's direct or indirect competition across all of the common fundamentals between BioNeutra Global and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioNeutra Global or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of BioNeutra Global's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioNeutra Global by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioNeutra Global to competition |
| Fundamentals | BioNeutra Global | Peer Average |
| Return On Equity | -2.55 | -0.31 |
| Return On Asset | -0.0573 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | (0.14) % | (5.51) % |
| Current Valuation | 5 M | 16.62 B |
| Shares Outstanding | 46.45 M | 571.82 M |
| Shares Owned By Insiders | 36.85 % | 10.09 % |
| Price To Sales | 0.25 X | 11.42 X |
| Revenue | 15.4 M | 9.43 B |
| Gross Profit | 2.89 M | 27.38 B |
| EBITDA | (1.12 M) | 3.9 B |
| Net Income | (2.83 M) | 570.98 M |
| Cash And Equivalents | 1.93 M | 2.7 B |
| Cash Per Share | 0.04 X | 5.01 X |
| Total Debt | 6.34 M | 5.32 B |
| Current Ratio | 0.69 X | 2.16 X |
| Book Value Per Share | (0.03) X | 1.93 K |
| Cash Flow From Operations | 271.05 K | 971.22 M |
| Earnings Per Share | (0.02) X | 3.12 X |
| Number Of Employees | 6 | 18.84 K |
| Beta | 0.74 | -0.15 |
| Market Capitalization | 863.36 K | 19.03 B |
| Total Asset | 21.08 M | 29.47 B |
| Net Asset | 21.08 M |
BioNeutra Global Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioNeutra . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioNeutra Global Buy or Sell Advice
When is the right time to buy or sell BioNeutra Global? Buying financial instruments such as BioNeutra Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioNeutra Global in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioNeutra Pink Sheet
BioNeutra Global financial ratios help investors to determine whether BioNeutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioNeutra with respect to the benefits of owning BioNeutra Global security.